Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome
NCT03263819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2024-07-08
Summary
Patients with POTS experience significant gastrointestinal symptoms. Current evidence suggesting that abnormal post-ganglionic sympathetic function could play a role in the pathophysiology of these GI abnormalities. Sympathetic fiber regulate motor and the postprandial GI peptides secretion.
The focus of the present proposal is to determine glucose homeostasis, GI motility, and their association with GI and cardiovascular symptoms in POTS patients versus healthy controls. Furthermore, we will determine differences in these outcomes in POTS patients with and without evidence of postganglionic sympathetic fiber neuropathy.
As a long-term goal, this study can lead us to understand the pathophysiology of common co-morbidities in patients with POTS to provide new treatment approaches and prevention strategies.
Conditions
- Postural Tachycardia Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Oral glucose tolerance test
75 grams of glucose
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
cyndya shibao · Vanderbilt University Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-20
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Use of Domperidone for Gastroparesis
NCT01378884 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of Food Hypersensitivity in Children/Adolescents With Functional Dyspepsia
NCT00328679 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions
NCT06846359 ·Status: RECRUITING ·Phase: NA
-
Gut Hormone, Nociceptors, Neurotrophic Factors Expression in Functional Dyspepsia
NCT02173925 ·Status: COMPLETED
-
Gastroparesis Registry 4
NCT05846802 ·Status: RECRUITING
-
Comparing Pertechnetate SPECT/CT and Intragastric Pressure During Nutrient Drink for Gastric Accommodation
NCT06673719 ·Status: COMPLETED ·Phase: NA
-
The Effect of Early Enteral Nutrition Feeding Process Assisted by Gastrointestinal Ultrasonography
NCT05379582 ·Status: COMPLETED ·Phase: NA
-
Nutritional Drink in Gastroparesis
NCT03500354 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
NCT00308399 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Octreotide in Non Variceal Bleeding
NCT06062719 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of CRH on Duodenal Markers and Gastric Sensorimotor Function
NCT05071781 ·Status: COMPLETED ·Phase: PHASE4
-
GI-Challenge Study for Gastroparesis Patients and Healthy Controls
NCT03896126 ·Status: TERMINATED
-
Functional GI Disease Registry
NCT05295446 ·Status: ENROLLING_BY_INVITATION
-
Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction
NCT06205446 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Symptoms in COVID-19
NCT04691895 ·Status: UNKNOWN
-
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
NCT02232308 ·Status: COMPLETED ·Phase: PHASE1
-
Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis
NCT01519180 ·Status: COMPLETED
-
Feasibility and Safety of Ttransendoscopic Enteral Tubing in Mid-gut
NCT03335982 ·Status: UNKNOWN ·Phase: NA
-
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
NCT01316484 ·Status: COMPLETED
-
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT06931223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pioglitazone for Idiopathic Gastroparesis
NCT04300127 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Gastric Motor Function Measurement in Dyspepsia and Normal Subjects
NCT00296582 ·Status: COMPLETED ·Phase: NA
-
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
NCT01173484 ·Status: TERMINATED
-
Effect of Secretin in Functional Dyspepsia and Healthy Subjects
NCT03617861 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tradipitant for Functional Dyspepsia
NCT05653310 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2